Xavier Van Rillaer

Xavier Van Rillaer is the Head of Finance and Controlling at AgomAb Therapeutics, leveraging a background in capital markets auditing from his time at BDO. He holds an MBA from Vlerick Business School, applying his financial expertise to drive growth in the innovative biotech space.

Xavier is a vocal supporter of his colleagues and his companys mission. He frequently celebrates team achievements and clinical development milestones, showing a strong belief in the importance of collaboration to advance the European life sciences ecosystem.

He has played a key role in Agomabs significant fundraising successes, including a $100 million Series C and an $89 million Series D round.